Ultra-low freezers, or ULTs, are specialised refrige-rating equipment created to store vaccines, medicines, and samples at ultra-low temperatures. By offering storage temperatures ranging from -20°C to -86°C and energy efficiency, B Medical Systems’ ULTs create an ideal environment for the long-term storage of extremely temperature-sensitive biologicals, making its products perfect for use in laboratory or clinical environments.
Tough times for cancer cell therapies
BackgroundSo far, no gene and cell therapies have been approved to treat solid tumours. European Biotechnology spoke with Karen Miller, SVP Pipeline Research at Adaptimmune plc, about promising candidates, and the art of circumventing supply chain bottlenecks caused by the COVID-19 pandemic.
Richter-Helm triples capacity at Bovenau site
Sponsored PublicationsRichter-Helm, a leading steadily growing Germany-based contract development and manufacturing organization (CDMO), offers excellent services in the continuously growing market of pharmaceutical biotechnology. Two additional bioreactors with capacities of 300 litres and 1,500 litres for microbial production will be added. This includes also the establishment of mid- and downstream processing and supporting utilities on a total area of about 10,000 m².
International control of hemp and cannabinoids
Sponsored PublicationsFor a plant that has been used for millennia, controls on the supply of psychoactive and non-psychoactive components extracted from cannabis are relatively recent, with global regulations starting in the 20th century with the International Opium Conventions. The current, and often conflicting, regulatory landscape has focused on definitions of hemp and cannabidiol (CBD). Reference materials are critical to defining the % ?9-THC in these products.
B Medical Systems’ reliable ultra-low freezers
Sponsored PublicationsUltra-low freezers, or ULTs, are specialised refrige-rating equipment created to store vaccines, medicines, and samples at ultra-low temperatures. By offering storage temperatures ranging from -20°C to -86°C and energy efficiency, B Medical Systems’ ULTs create an ideal environment for the long-term storage of extremely temperature-sensitive biologicals, making its products perfect for use in laboratory or clinical environments.
Lonza expands EU production capacity for Moderna vaccine
Latest NewsLonza will expand its production capacity of Moderna’s mRNA vaccine mRNA1273 at its manufacturing site in Geelen, the Netherlands.
EU approves Biontech/Pfizer vaccine for adolescents
Latest NewsThe European Medicines Agency (EMA) has given the green light for vaccination of adolescents with Biontech’s COVID-19 vaccine Comirnaty (BNT162b2).
Current EU GMO legislation is not fit for purpose
OpinionThe Commission study on Novel Genomic Techniques (NGTs) underlines that plants resulting from NGTs have the potential to contribute to a more sustainable food system and support the objectives of the European Green Deal and the Farm to Fork Strategy. At the same time, the study finds that the current GMO legislation, adopted in 2001, is not fit for purpose for these innovative technologies.
Providing access to Covid-19 medicines and vaccines
OpinionIP U.S. reverses stance, backs giving poorer countries access to COVID vaccine patents:
President Joe Biden in May threw his support behind waiving intellectual property rights
for COVID-19 vaccines – very much to the surprise of the biotech world.
Pandemic demand drives skills and production gap
Sponsored PublicationsThe life sciences industry stepped up its pace in the last year to rapidly fill a void in the fight against COVID-19. Solis BioDyne is one of many companies that have experienced a dramatic increase in demand for its solutions during the pandemic especially for products used in COVID-19 diagnostic tests. The company knew it needed to ramp up production. And time was not on their side.
Senti Bio and Bluerock ink Regmed collaboration
Latest NewsSenti Biosciences and Bayer subsidiary BlueRock Therapeutics form strategic partnership to combine iPSC and gene circuit-engineered cell therapy platforms.